Table 5.

Suggested criteria for the consideration of secondary cytoreductive surgery over medical management for recurrent endometrial cancer based on clinicopathologic and initial surgical features

	Higher Consideration	Lower Consideration
Features from time of diagnosis	Age ≤ 70 at initial diagnosis PFS1 ≥ 19 months Endometrioid/Clear cell FIGO Grade 1/2 Early stage I/II disease at diagnosis	BMI
Features from primary surgery	No residual disease Hospital stay ranging from 0–6 days Received adjuvant radiation therapy	Received adjuvant chemotherapy
Features at time of recurrence	Single site of disease	Size of tumor Distant site of recurrence

PFS1, time interval from initial surgery to first progression/recurrence; BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics